Clinical Trial Update: Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 results update for liposomal doxorubicin (Doxil) and carboplatin in metastatic breast cancer, highlighting activity in HER2-positive disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Doxil (liposomal doxorubicin)

Snippet

Sponsor: US Oncology Research | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-11-03